Emerging drugs for attention-deficit/hyperactivity disorder
1Duke University Medical Center, Durham, NC, USA. rweisler@aol.com
Expert Opinion on Emerging Drugs
|September 19, 2007
Summary
Attention-deficit/hyperactivity disorder (ADHD) treatments are evolving, with new long-acting medications improving adherence. Future research focuses on novel pharmacotherapies targeting catecholamine pathways for better symptom control.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Attention-deficit/hyperactivity disorder (ADHD) presents heterogeneous symptoms and frequent comorbidities.
- While ADHD symptoms often decrease with age, many individuals experience them into adulthood.
- Current ADHD medications are not universally effective, necessitating ongoing therapeutic development.
Purpose of the Study:
- To review current advancements in ADHD pharmacotherapy.
- To identify the need for improved, long-acting ADHD medications with reduced abuse potential.
- To explore emerging therapeutic targets and agents for ADHD treatment.
Main Methods:
- Review of recent literature on ADHD pharmacotherapy and delivery systems.
- Analysis of catecholamine pathways' role in executive function and ADHD symptoms.
- Exploration of potential future pharmacotherapies.
Main Results:
- Long-acting formulations and transdermal systems enhance medication effectiveness and patient compliance.
- There is a continuing need for safe, well-tolerated, long-acting ADHD medications with low abuse potential.
- Catecholamine pathways are a key focus for understanding and treating ADHD.
- Several novel therapeutic agents targeting adrenergic, glutamatergic, GABAergic, and cholinergic systems are under investigation.
Conclusions:
- Advances in drug delivery have improved ADHD management, but further innovation is required.
- Future ADHD pharmacotherapies may involve targeting specific neurotransmitter systems beyond traditional stimulants.
- Research into novel agents offers promise for more effective and safer ADHD treatment options.
More Related Videos
Related Concept Videos
01:30Attention-Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
01:24CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its effects by...
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:21Drugs Affecting Neurotransmitter Release or Uptake
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications